Safety and stability of lipid emulsions

Nutrition in Clinical Practice

Volumn 22, Issue 3, 2007, Pages 367-369

  Zaloga, Gary P ^a   Dunham, Andrew J ^a   Gonyon, Thomas M ^a   Best, Lynn M ^a   Groves, Mike ^b  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; FATTY ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID EMULSION; MALONALDEHYDE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOPSY; CYTOKINE PRODUCTION; DRUG SAFETY; DRUG STABILITY; EXPERIMENTAL MODEL; FAT EMBOLISM; FATTY ACID BLOOD LEVEL; GUINEA PIG; HUMAN; LETTER; LIPID TRANSPORT; LIVER; LUNG FUNCTION; NONHUMAN; PATHOPHYSIOLOGY; RETICULOENDOTHELIAL SYSTEM; SOYBEAN; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; ANIMAL; EVIDENCE BASED MEDICINE; NOTE; PARENTERAL NUTRITION; PARTICLE SIZE; RAT; SAFETY; STANDARD;

ANIMALS; DRUG STABILITY; EVIDENCE-BASED MEDICINE; FAT EMULSIONS, INTRAVENOUS; HUMANS; PARENTERAL NUTRITION; PARTICLE SIZE; RATS; SAFETY;

EID: 58949091690     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426507022003367     Document Type: Letter

References (14)

1. Driscoll DF. Lipid injectable emulsions: 2006. Nutr Clin Pract. 2006;21:381-386.
2. Driscoll DF, Ling PR, Quist WC, Bistrian BR. Pathological consequences from the infusion of unstable lipid emulsion admixtures in guinea pigs. Clin Nutr. 2005;24:105-113.
3. Driscoll DF, Ling P, Bistrian BR. Hepatic indicators of inflammation following the infusion of pharmaceutically unstable all-in-one mixtures (AIO) in rats [abstract]. Clin Nutr. 2003;22(S16-S17): 059-O.
4. Driscoll DF, Ling PR, Bistrian BR. Pathological consequences to reticuloendothelial system organs following infusion of unstable all-in-one mixtures in rats. Clin Nutr. 2006;25:842-850.
5. USP Chapter <729>. Globule size distribution in injectable lipid emulsions. In: US Pharmacopoeial Forum Vol. 31 (5) [Sep-Oct 2005]. Rockville, MD: US Pharmacopoeial Convention, Inc; 2005.
6. Rey JB, Faure C, Brion F. Stability of all-in-one standard formulae for paediatric parenteral nutrition. PDA J Pharm Sci Tech. 2005;59:206-220.
7. Mehta RC, Head LF, Hazrati AM, Parr M, Rapp RP, DeLuca PP. Fat emulsion particle-size distribution in total nutrient admixtures. Am J Hosp Pharmacy. 1992;49:2749-2755.
8. Tannuri U, Sesso A, Coelho MC, Maksoud JG. Long term stability of lipid emulsions with parenteral nutrition solutions. Nutrition. 1992;8:98-100.
9. Deitel M, Friedman KL, Cunnane S, et al. Emulsion stability in a total nutrient admixture for total parenteral nutrition. J Am Coll Nutr. 1992;11:5-10.
10. Bullock L, Fitzgerald JF, Walter WV. Emulsion stability in total nutrient admixtures containing a pediatric amino acid formulation. JPEN J Parenter Enteral Nutr. 1992;16:64-68.
11. Sayeed FA, Tripp MG, Sukumaran KB, Mikrut BA, Stelmach HA, Raihle JA. Stability of total nutrient admixtures using various intravenous fat emulsions. Am J Hosp Pharm. 1987;44:2271-2280.
12. Driscoll DF, Bhargava HN, Zaim RH, Babayan VK, Bistrian BR. Physiochemical stability of total nutrient admixtures. Am J Health Syst Pharm. 1995;52:623-634.
13. Mirtallo J, Canada T, Johnson D, et al; Task Force for the Revision of Safe Practices for Parenteral Nutrition. Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004;28:S39-S70. Erratum 2006;30:177.
14. Driscoll DF, Bistrian BR. The effects of packaging containers on the large-diameter tail of the globule size distribution (GSD) of lipid emulsions [abstract]. Clin Nutr. 2005;24:699.